What is AptarGroup's pharma — other segment items:?

AptarGroup (ATR) reported pharma — other segment items: of -$4.32M in Q1 2026.

How has AptarGroup's pharma — other segment items: changed year-over-year?

AptarGroup's pharma — other segment items: decreased by 615.6% year-over-year, from -$603K to -$4.32M.

What does pharma — other segment items: mean?

Captures miscellaneous income or expenses specific to the pharma segment that do not fall into standard operating categories. This may include restructuring charges, legal settlements, or non-recurring gains/losses.

AptarGroup ATR Pharma — Other Segment Items:

Other segment segments

Beauty

-$965K—

Closures

$188K—

Similar metrics at other companies

VRTXPharmaceuticals — Other Segment items

$200K-99.0%

BAXPharmaceuticals — Other segment items

-$7M0.0%

TMOLaboratory Products and Biopharma Services — Other segment items

-$110M-6.8%

BDXBioPharma Systems — Segment Other Operating Expense (Income), net as a Percent of Revenues

0%—

BAXMedical Products & Therapies — Other segment items

-$26M-23.8%

PSXChemicals — Other segment items

$0—

Other financials

Income statement

See full

Revenue$982.9M+10.8%

Gross profit$351.9M+4.6%

Operating income$107.5M-5.2%

Net income$72.7M-7.8%

EPS (diluted)$1.12-4.3%

Balance sheet

See full

Cash & equivalents$225.0M+78.8%

Total debt$1.4B+32.7%

Total equity$2.6B+3.6%

Total assets$5.1B+12.6%

Cash flow

See full

Operating cash flow$118.7M+43.5%

CapEx$65.4M+15.0%

Free cash flow$53.3M+106%

Valuation

See full

Market cap$7.68B-17.9%

Enterprise value$8.89B-13.9%

P/E19.9×-5.4×

P/S2×-0.6×

Profitability

See full

Gross margin36.7%-1.6pp

Operating margin12.8%-1.2pp

Net margin10%-0.4pp

FCF margin8.4%-2.1pp

Returns & leverage

See full

Return on equity15%-0.2pp

Debt / equity0.5×+0.1×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's pharma — other segment items:.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AptarGroup's pharma — other segment items:?: AptarGroup (ATR) reported pharma — other segment items: of -$4.32M in Q1 2026.
How has AptarGroup's pharma — other segment items: changed year-over-year?: AptarGroup's pharma — other segment items: decreased by 615.6% year-over-year, from -$603K to -$4.32M.
What does pharma — other segment items: mean?: Captures miscellaneous income or expenses specific to the pharma segment that do not fall into standard operating categories. This may include restructuring charges, legal settlements, or non-recurring gains/losses.